Andrew Fein
Stock Analyst at HC Wainwright & Co.
(2.43)
# 2,275
Out of 4,826 analysts
606
Total ratings
39.5%
Success rate
-0.08%
Average return
Main Sectors:
Stocks Rated by Andrew Fein
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Maintains: Buy | $7 → $16 | $8.95 | +78.77% | 12 | May 5, 2025 | |
| BIIB Biogen | Maintains: Buy | $241 → $187 | $123.53 | +51.38% | 20 | May 2, 2025 | |
| ARVN Arvinas | Maintains: Buy | $81 → $24 | $7.72 | +210.88% | 19 | May 2, 2025 | |
| BPMC Blueprint Medicines | Reiterates: Buy | $135 | $104.64 | +29.01% | 18 | May 2, 2025 | |
| ACIU AC Immune | Maintains: Buy | $16 → $12 | $1.72 | +597.67% | 16 | May 1, 2025 | |
| PVLA Palvella Therapeutics | Reiterates: Buy | $38 | $23.94 | +58.73% | 6 | Apr 30, 2025 | |
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.54 | +214.96% | 2 | Apr 28, 2025 | |
| NBIX Neurocrine Biosciences | Maintains: Buy | $185 → $168 | $109.68 | +53.17% | 20 | Apr 22, 2025 | |
| INSM Insmed | Reiterates: Buy | $90 | $72.30 | +24.48% | 14 | Apr 22, 2025 | |
| GPCR Structure Therapeutics | Maintains: Buy | $80 | $27.09 | +195.31% | 4 | Apr 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $0.94 | +644.68% | 13 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $14.65 | +173.04% | 14 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $11 | $1.08 | +918.52% | 11 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $3.40 | +76.47% | 12 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.45 | +589.66% | 18 | Mar 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $8.10 | +171.60% | 12 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $29 | $15.83 | +83.20% | 12 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $47 | $9.63 | +388.06% | 13 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $72 | $32.20 | +123.60% | 4 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $11.86 | +287.86% | 11 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $2 | $1.10 | +81.82% | 16 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $2.73 | +412.82% | 13 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $13.55 | +47.60% | 14 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $12 | $1.99 | +503.02% | 12 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $13 | $4.24 | +206.60% | 14 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $6.66 | +65.17% | 10 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $23 | $3.58 | +542.46% | 14 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.60 | +837.50% | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $12 | $5.32 | +125.56% | 19 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $44.19 | +92.35% | 16 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $35 | $24.84 | +40.90% | 14 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $60 | $35.28 | +70.07% | 7 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $87 | $16.47 | +428.39% | 21 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $14.91 | +81.09% | 18 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $425 | $294.60 | +44.26% | 14 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $1.30 | +438.46% | 9 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $4 | $5.62 | -28.83% | 17 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $8.93 | +235.95% | 9 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $1.59 | +906.29% | 11 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $48 | $8.49 | +465.37% | 16 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $7.79 | +862.77% | 7 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $550 | $501.15 | +9.75% | 26 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $75 | $29.05 | +158.18% | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $1.97 | +1,422.84% | 14 | Dec 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 | $1.12 | +614.29% | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $7 | $1.74 | +302.30% | 6 | Nov 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $6.38 | +56.74% | 5 | Aug 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $40 | $2.04 | +1,865.60% | 3 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $150 | $0.59 | +25,302.20% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $200 → $60 | $10.91 | +449.95% | 4 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $2.81 | +433.81% | 1 | Apr 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $40 | $1.80 | +2,122.22% | 3 | Mar 16, 2022 |
DBV Technologies
May 5, 2025
Maintains: Buy
Price Target: $7 → $16
Current: $8.95
Upside: +78.77%
Biogen
May 2, 2025
Maintains: Buy
Price Target: $241 → $187
Current: $123.53
Upside: +51.38%
Arvinas
May 2, 2025
Maintains: Buy
Price Target: $81 → $24
Current: $7.72
Upside: +210.88%
Blueprint Medicines
May 2, 2025
Reiterates: Buy
Price Target: $135
Current: $104.64
Upside: +29.01%
AC Immune
May 1, 2025
Maintains: Buy
Price Target: $16 → $12
Current: $1.72
Upside: +597.67%
Palvella Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $38
Current: $23.94
Upside: +58.73%
ImmunityBio
Apr 28, 2025
Reiterates: Buy
Price Target: $8
Current: $2.54
Upside: +214.96%
Neurocrine Biosciences
Apr 22, 2025
Maintains: Buy
Price Target: $185 → $168
Current: $109.68
Upside: +53.17%
Insmed
Apr 22, 2025
Reiterates: Buy
Price Target: $90
Current: $72.30
Upside: +24.48%
Structure Therapeutics
Apr 22, 2025
Maintains: Buy
Price Target: $80
Current: $27.09
Upside: +195.31%
Apr 4, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $0.94
Upside: +644.68%
Apr 1, 2025
Reiterates: Buy
Price Target: $40
Current: $14.65
Upside: +173.04%
Mar 28, 2025
Maintains: Buy
Price Target: $15 → $11
Current: $1.08
Upside: +918.52%
Mar 28, 2025
Reiterates: Buy
Price Target: $6
Current: $3.40
Upside: +76.47%
Mar 27, 2025
Reiterates: Buy
Price Target: $10
Current: $1.45
Upside: +589.66%
Mar 26, 2025
Reiterates: Buy
Price Target: $22
Current: $8.10
Upside: +171.60%
Mar 20, 2025
Reiterates: Buy
Price Target: $29
Current: $15.83
Upside: +83.20%
Mar 19, 2025
Reiterates: Buy
Price Target: $47
Current: $9.63
Upside: +388.06%
Mar 18, 2025
Reiterates: Buy
Price Target: $72
Current: $32.20
Upside: +123.60%
Mar 17, 2025
Reiterates: Buy
Price Target: $46
Current: $11.86
Upside: +287.86%
Mar 17, 2025
Downgrades: Neutral
Price Target: $12 → $2
Current: $1.10
Upside: +81.82%
Mar 14, 2025
Maintains: Buy
Price Target: $17 → $14
Current: $2.73
Upside: +412.82%
Mar 14, 2025
Reiterates: Buy
Price Target: $20
Current: $13.55
Upside: +47.60%
Mar 14, 2025
Maintains: Buy
Price Target: $10 → $12
Current: $1.99
Upside: +503.02%
Mar 7, 2025
Reiterates: Buy
Price Target: $13
Current: $4.24
Upside: +206.60%
Mar 6, 2025
Reiterates: Buy
Price Target: $11
Current: $6.66
Upside: +65.17%
Mar 6, 2025
Reiterates: Buy
Price Target: $23
Current: $3.58
Upside: +542.46%
Mar 6, 2025
Reiterates: Buy
Price Target: $15
Current: $1.60
Upside: +837.50%
Mar 5, 2025
Reiterates: Buy
Price Target: $12
Current: $5.32
Upside: +125.56%
Mar 3, 2025
Reiterates: Buy
Price Target: $85
Current: $44.19
Upside: +92.35%
Feb 28, 2025
Reiterates: Buy
Price Target: $35
Current: $24.84
Upside: +40.90%
Feb 28, 2025
Maintains: Buy
Price Target: $54 → $60
Current: $35.28
Upside: +70.07%
Feb 28, 2025
Maintains: Buy
Price Target: $80 → $87
Current: $16.47
Upside: +428.39%
Feb 27, 2025
Reiterates: Buy
Price Target: $27
Current: $14.91
Upside: +81.09%
Feb 27, 2025
Reiterates: Buy
Price Target: $425
Current: $294.60
Upside: +44.26%
Feb 27, 2025
Reiterates: Buy
Price Target: $7
Current: $1.30
Upside: +438.46%
Feb 26, 2025
Reiterates: Neutral
Price Target: $4
Current: $5.62
Upside: -28.83%
Feb 25, 2025
Reiterates: Buy
Price Target: $30
Current: $8.93
Upside: +235.95%
Feb 24, 2025
Reiterates: Buy
Price Target: $16
Current: $1.59
Upside: +906.29%
Feb 24, 2025
Reiterates: Buy
Price Target: $48
Current: $8.49
Upside: +465.37%
Feb 18, 2025
Reiterates: Buy
Price Target: $75
Current: $7.79
Upside: +862.77%
Feb 11, 2025
Reiterates: Buy
Price Target: $550
Current: $501.15
Upside: +9.75%
Jan 13, 2025
Reiterates: Buy
Price Target: $75
Current: $29.05
Upside: +158.18%
Dec 17, 2024
Reiterates: Buy
Price Target: $30
Current: $1.97
Upside: +1,422.84%
Aug 8, 2024
Reiterates: Buy
Price Target: $8
Current: $1.12
Upside: +614.29%
Nov 2, 2023
Maintains: Buy
Price Target: $17 → $7
Current: $1.74
Upside: +302.30%
Aug 15, 2023
Reiterates: Buy
Price Target: $10
Current: $6.38
Upside: +56.74%
Feb 13, 2023
Maintains: Buy
Price Target: $100 → $40
Current: $2.04
Upside: +1,865.60%
Jan 31, 2023
Reiterates: Buy
Price Target: $150
Current: $0.59
Upside: +25,302.20%
May 5, 2022
Downgrades: Neutral
Price Target: $200 → $60
Current: $10.91
Upside: +449.95%
Apr 27, 2022
Assumes: Buy
Price Target: $15
Current: $2.81
Upside: +433.81%
Mar 16, 2022
Maintains: Neutral
Price Target: $80 → $40
Current: $1.80
Upside: +2,122.22%